Kestra Medical Technologies

The company designs, manufactures, and sells a wearable cardioverter defibrillator for patients at higher risk of cardiac arrest. Incorporated in Bermuda, it is commercializing a cardiac recovery system platform—an advanced, comprehensive system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single unified solution.

Its ASSURE WCD is a next-generation wearable cardioverter defibrillator (WCD) designed to protect patients at an elevated risk of sudden cardiac arrest. Since its commercial launch in August 2022, more than 17,000 patients have worn the ASSURE WCD. As of January 31, 2025, the company's cardiac recovery system is actively prescribed by more than 550 U.S. hospitals.